β-Adrenoceptor regulation in insulin-dependent diabetes mellitus

References

• Christensen N J, Alberti K GMM, Brandsborg O. Plasma catecholamines and blood substrate concentrations: studies in insulin-induced hypo-glycaemia and after adrenaline infusions. Eur J Clin Invest 1975; 5: 415–23
   PubMed Web of Science ®Google Scholar
• Garber A J, Cryer P E, Santiago J V, Haymond M W, Pagliara A S, Kipnis D M. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest 1976; 58: 7–15
   PubMed Web of Science ®Google Scholar
• Sacca L, Sherwin R, Hendler R, Felig P. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. J Clin Invest 1979; 63: 849–57
   PubMed Web of Science ®Google Scholar
• Bolli G, De Feo P, Compagnucci P, Cartechini M G, Angeletti G, Santeusanio F, Brunetti P. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycaemia in type I diabetes. Diabetes 1982; 31: 641–7
   PubMedGoogle Scholar
• Kocrker D J, Halter J B. Glucorcgulation during insulin and glucagon deficiency: role of catecholamines. Am J Physiol 1982; 243: 225–33
   Google Scholar
• Popp D A, Shah S D, Cryer P E. Role of epine-phrine-mediated β-adrenergic mechanisms in hypoglycaemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. J Clin Invest 1982; 69: 315–26
   PubMedGoogle Scholar
• De Feo P, Bolli G, Perriello G, De Cosmo S, Compagnucci P, Angeletti G, Santeusanio F, Gerich J E, Motolese M, Brunetti P. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Diabetes 1983; 32: 887–93
   PubMedGoogle Scholar
• Hoeldtke R D, Bodcn G, Shuman C R, Owen O E. Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med 1982; 96: 459–62
   PubMedGoogle Scholar
• Adamson U, Lins P-E, Efendic S, Hamberger B, Wajngot A. Impaired counter regulation of hypoglycemia in a group of insulin-dependent diabetics with recurrent episodes of severe hypoglycaemia. Acta Med Scand 1984; 216: 215–22
   PubMed Web of Science ®Google Scholar
• Polonsky K, Bergenstal R, Pons G, Schneider M, Jaspan J, Rubinstein A. Relation of counter-regulatory responses to hypoglycemia in type I diabetics. N Engl J Med 1982; 307: 1106–12
   PubMed Web of Science ®Google Scholar
• Bergenstal R M, Polonsky K S, Pons G, Jaspan J B, Rubinstein A H. Lack of glucagon response to hypoglycemia in type I diabetics after long-term optimal therapy with a continuous subcutaneous insulin infusion pump. Diabetes 1983; 32: 398–402
   PubMed Web of Science ®Google Scholar
• Noji T, Tashiro M, Yagi H, Nagashima K, Suzuki S, Kuroume T. Adaptive regulation of β-adrenergic receptors in children with insulin dependent diabetes mellitus. Horm Metab Res 1986; 18: 604–6
   PubMedGoogle Scholar
• Berlin I, Grimaldi A, Bosquet F, Puech A J. Decreased β-adrenergic sensitivity in insulin-dependent diabetic subjects. J Clin Endocrin Metab 1986; 63: 262–5
   PubMedGoogle Scholar
• Serusclat P, Rosen S G, Smith E B, Shah S D, Clutter W E, Cryer P E. Mononuclear leukocyte β2adrenergic receptors and adenylate cyclase sensitivity in insulin-dependent diabetes mellitus. Diabetes 1983; 32: 825–9
   PubMedGoogle Scholar
• Bøyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 1968; 21((Suppl. 97))77–89
   PubMed Web of Science ®Google Scholar
• Sandnes D, Gjerde I, Refsnes M, Jacobsen S. Down-regulation of surface beta-adrenoceptors on intact human mononuclear leukocytes. Biochem Pharmacol 1987; 36: 1303–11
   PubMed Web of Science ®Google Scholar
• Sager G, Lyberg T, Prydz H, Christoffersen T, Jacobsen S. Effect of serum on isoproterenol-induced cyclic AMP accumulation in human lymphocytes. Acta Pharmacol Toxicol 1985; 57: 197–203
   PubMedGoogle Scholar
• Skomedal T, Grynne B, Osnes J B, Sjetnan A, Øye I. A radioimmunoassay for cyclic AMP (cAMP) obtained by acetylation of both unlabeled and labeled (3H-cAMP) ligand or of unlabeled ligand only. Acta Pharmacol Toxicol 1980; 46: 200–4
   PubMedGoogle Scholar
• Sager G, Trovik T, Slørdal L, Jaeger R, Prytz P S, Brox J, Reikerås O. Catecholamine binding and concentrations in acute phase plasma after surgery. Scand J Clin Lab Invest 1988; 48: 419–24
   PubMed Web of Science ®Google Scholar
• McPherson G A. Analysis of radioligand binding experiments. J Pharmacol Methods 1985; 14: 213–28
   PubMedGoogle Scholar
• Munson P J, Rodbard D. LIGAND: a versatile computerized approach for the characterization of ligand binding systems. Anal Biochem 1980; 107: 220–39
   PubMed Web of Science ®Google Scholar
• Williams L T, Snyderman R, Lefkowitz R J. Identification of β-adrenergic receptors in human lymphocytes by (-) (3H)alprenolol binding. J Clin Invest 1976; 57: 149–55
   PubMed Web of Science ®Google Scholar
• O'Hara N, Daul A E, Fesel R, Siekmann U, Brodde O-E. Different mechanisms underlying reduced β2-adrenoceptor responsiveness in lymphocytes from neonates and old subjects. Mechanisms Ageing Devel 1985; 31: 115–122
   PubMed Web of Science ®Google Scholar
• Liggett S E, Marker J C, Shah S D, Roper C L, Cryer P E. Direct relationship between mononuclear leukocyte and lung β-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, α- and β-adrenergic receptors by sympathochromaffin system in humans. J Clin Invest 1988; 82: 48–56
   PubMedGoogle Scholar
• Michel M C, Pingsmann A, Beckeringh J J, Zerkowski H-R, Doetsch N, Brodde O-E. Selective regulation of β1 and β2 adrenoceptors in the human heart by chronic -adrenoceptor antagonist treatment. Br J Pharmacol 1988; 94: 685–92
   PubMedGoogle Scholar
• Krall J F, Connelly M, Tuck M L. Acute regulation of beta adrenergic catecholamine sensitivity in human lymphocytes. J Pharmacol Exp Ther 1980; 214: 554–60
   PubMed Web of Science ®Google Scholar